ReleaseWire Connect

With a larger pool of players operating domestically and a smaller bunch of international participants, the global platelet-rich plasma (PRP) market demonstrates a semi-consolidated landscape. The top five players, namely, Harvest Technologies, Arthrex Inc., Zimmer Biomet, DePuy Synthes, and Stryker Corp. accounted for more than 80% of this market in 2015. Most of these are headquartered in North America. However, their focus is likely to shift towards emerging economies across Asia Pacific in the coming years, as this region is expected to offer lucrative opportunities on account of untapped potential.

Alipogene Tiparvovec has shown great results as a gene therapy used in the treatment of lipoprotein lipase deficiency (LPLD). LPLD is a rare condition, mostly inherited, that occurs coupled with increased accumulation of fat in blood, which can later cause severe pancreatitis. Alipogene Tiparvovec is one of the first therapeutic cures administered to LPLD patients. Prior this, patients were advised severe dietary restriction. A few others were administered with medium-chain triglycerides that held risk of pancreatitis or disease progression.

Antithrombin Market : Segmental Highlights and Table of Content (2017 - 2025)

Transparency Market Research (TMR) has recently published a market study on the global E-clinical solution software market, estimating the market to expand at a CAGR of 13.80% during the period from 2014 to 2020 and reach a market value of US$6.8 bn by the end of the forecast period.The research report, titled "E-Clinical Solution Software Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020", states that the worldwide E-clinical solution software market stood at US$3 bn in 2014. The rising number of clinical trials has been considered as the key driving force behind the growth of this market.

The top five players in the wearable medical devices market accounted for a combined market share of 47.0% in 2014, which leads to some degree of consolidation in an otherwise fragmented market. Some of the leading companies are Polar Electro, Fitbit, Inc., OMRON Corporation, and Medtronic, with OMRON Corporation holding a significant revenue share of almost 11.0% in the same year. The global electronics company increasingly focuses on home healthcare devices, usually portable medical devices such as pedometers and blood pressure monitors to strengthen its shares. Another major player Fitbit, Inc., pioneers in offering wearable technology devices for tracking fitness to gain a competitive edge over others.

The competitive scenario in the Asia preimplantation genetic diagnostics market is highly intense owing to the several global and local players trying their luck in the region, states Transparency Market Research (TMR) in a research report. Pertaining to the number of service providers of preimplantation genetic diagnosis market, it is a highly fragmented one in nature. The penetration of other regional players might further intensify the level of competition in the market in the years ahead. Some of the companies operating in the market might be F. Hoffmann-La Roche, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Illumina Inc., Natera Inc., and Abbott Laboratories, among many others.

The X-ray photoelectron spectroscopy (XPS) market is characterized by the presence of large regional players, particularly in several developed nations. Prominent players operating in the market include Thermo Fisher Scientific, ULVAC-PHI, Japan Electron Optics (JEOL) Ltd., Evans Analytical Group LLC., and Kratos Analytical Ltd. Leading companies are consolidating their presence in various emerging markets such as China, India, and Australian, notes Transparency Market Research (TMR). Top players are actively capitalizing on numerous opportunities opening up there, in a move to strengthen their shares.

The international healthcare supplies market is currently riding on the demand for early detection of diseases for effective treatment and introduction of sophisticated medical devices by the leading firms in the industry. Hospital acquired infections (HAIs) are a serious issues in the healthcare industry and have increased the need for the implementation of top-end healthcare supplies even more.

The research report offers deep understanding of the disinfectant equipments market structure. It investigates different aspects, and explains quantitative as well as qualitative analysis patterns. It divides the market on the basis of different logical parameters and examines each segment and sub-segment in the overall industry. The factors that drive as well as restrain the growth of the industry have been described, helping companies take important steps for their business futures. The report explains the importance of sterilization and disinfectant methods and chemicals for the control of infections in healthcare facilities including hospitals, laboratories, and clinics. It utilizes all regulatory discretions that aim to control the usage of chemicals in the disinfectant equipments market.

The nature of the business landscape is highly consolidated with the alliances between the companies operating in the needle-free delivery devices market increasing, states Transparency Market Research (TMR) in a research report. The leading three companies, namely, Antares Pharma Inc., 3M, and Zogenix collectively held a share of over 60% in the global market for needle free drug delivery in 2014. Apart from partnerships, acquisitions, and mergers, the core vendors are now focusing on the introduction of advanced devices on the basis of novel technologies for strengthening their position in the market for the long run and staying competitive as well. Going forward, the huge swath of in fact propelled gadgets - in the pipeline at show - will additionally strengthen the opposition in the overall market for sans needle sedate conveyance gadgets sooner rather than later.